Accretive Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$637K Buy
4,954
+2
+0% +$234 0.15% 112
2026
Q1
$596K Buy
4,952
+308
+7% +$35.6K 0.17% 111
2025
Q4
$489K Sell
4,644
-545
-11% -$51.2K 0.15% 109
2025
Q3
$436K Hold
5,189
– – 0.13% 113
2025
Q2
$411K Sell
5,189
-100
-2% -$7.95K 0.13% 114
2025
Q1
$418K Sell
5,289
-53
-1% -$4.95K 0.15% 112
2024
Q4
$531K Buy
+5,342
New +$551K 0.23% 100

Other funds holding MRK

Accretive Wealth Partners's MRK Position: Q2 2026 in Review

Accretive Wealth Partners increased its Merck (MRK) stake by 0.04% in Q2 2026, buying an estimated $234 and bringing the position to 4,954 shares worth $637K. The position accounts for 0.15% of the portfolio, ranked #112.

Accretive Wealth Partners first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Accretive Wealth Partners held 4,954 shares of Merck worth $637K as of Q2 2026.
  • Accretive Wealth Partners bought 2 Merck shares in Q2 2026, an estimated $234.
  • Merck made up 0.15% of Accretive Wealth Partners's portfolio in Q2 2026, its #112 holding.
  • Accretive Wealth Partners first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Accretive Wealth Partners's 13F filing for Q2 2026, filed 29 Jul 2026.